Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases

Media coverage

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Sys-Con Italia
  Country/Territory	Italy
  Date	22/03/17
  URL	it.sys-con.com/node/4039252
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	BioSpace
  Country/Territory	United States
  Date	22/03/17
  URL	investor.biospace.com/biospace/news/read?GUID=33945452
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Nasdaq
  Country/Territory	United States
  Date	22/03/17
  URL	www.nasdaq.com/press-release/revive-therapeutics-appoints-dr-scott-friedman-md-as-scientific-advisor-for-cannabinoidbased-20170322-00242
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Canadian Business Journal
  Country/Territory	Canada
  Date	22/03/17
  URL	www.cbj.ca/revive-therapeutics-appoints-dr-scott-friedman-md-as-scientific-advisor-for-cannabinoid-based-therapeutics-targeting-liver-diseases/
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Sys-Con Media
  Country/Territory	United States
  Date	22/03/17
  URL	www.sys-con.com/node/4039252
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Sys-Con Belgium
  Country/Territory	Belgium
  Date	22/03/17
  URL	be.sys-con.com/node/4039252
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Sys-Con Australia
  Country/Territory	Australia
  Date	22/03/17
  URL	au.sys-con.com/node/4039252
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Sys-Con Canada
  Country/Territory	Canada
  Date	22/03/17
  URL	ca.sys-con.com/node/4039252
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	FirstWord Pharma
  Country/Territory	United States
  Date	22/03/17
  URL	www.firstwordpharma.com/node/1458199?tsid=28&region_id=4
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Daily Times Leader
  Country/Territory	United States
  Date	22/03/17
  URL	business.dailytimesleader.com/dailytimesleader/news/read?GUID=33945452
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	MarketWired
  Country/Territory	Canada
  Date	22/03/17
  URL	www.marketwired.com/press-release/revive-therapeutics-appoints-dr-scott-friedman-md-as-scientific-advisor-cannabinoid-tsx-venture-rvv-2204569.htm
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	FinanzNachrichten.de
  Country/Territory	Germany
  Date	22/03/17
  URL	www.finanznachrichten.de/nachrichten-2017-03/40246733-revive-therapeutics-appoints-dr-scott-friedman-md-as-scientific-advisor-for-cannabinoid-based-therapeutics-targeting-liver-diseases-256.htm
  Persons	Lynn Friedman

• Title	Revive Therapeutics Appoints Dr. Scott Friedman, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases
  Media name/outlet	Marketwired (formerly Canadian Corporate Newswire)
  Country/Territory	Canada
  Date	22/03/17
  Persons	Lynn Friedman